Dr.reddy's Laboratories Ltd — Ofloxacin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Ofloxacin · $3.7M export value · DGFT Verified
Dr.reddy's Laboratories Ltd is the #1 Indian exporter of Ofloxacin with $3.7M in export value and 74 verified shipments. Dr.reddy's Laboratories Ltd holds a 1.3% market share in Ofloxacin exports across 2 countries.
Dr.reddy's Laboratories Ltd — Ofloxacin Export Profile: Buyers & Destinations
Where Does Dr.reddy's Laboratories Ltd Export Ofloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $4.7M | 116 | 95.5% |
| SOUTH AFRICA | $100.0K | 2 | 2.0% |
| CANADA | $50.0K | 1 | 1.0% |
| KAZAKHSTAN | $50.0K | 1 | 1.0% |
| SINGAPORE | $16.0K | 3 | 0.3% |
| JAMAICA | $3.6K | 1 | 0.1% |
| BRAZIL | $0 | 4 | 0.0% |
Dr.reddy's Laboratories Ltd exports Ofloxacin to 7 countries. The largest destination is UNITED STATES accounting for 95.5% of Dr.reddy's Laboratories Ltd's Ofloxacin shipments, followed by SOUTH AFRICA (2.0%) and CANADA (1.0%). These destinations reflect Dr.reddy's Laboratories Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ofloxacin from Dr.reddy's Laboratories Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DR, REDDYS LABORATORIES, INC | UNITED STATES | $1.2M | 24 |
| NORTHSTAR DISTRIBUTION CENTRE 8912 | UNITED STATES | $800.0K | 16 |
| DR.REDDY'S LABORATORIES,INC | UNITED STATES | $700.0K | 14 |
| DR. REDDYS LABORATORIES, INC | UNITED STATES | $666.3K | 21 |
| DR REDDYS LABORATORIES,INC | UNITED STATES | $504.5K | 13 |
| DR. REDDY'S LABORATORIES, INC | UNITED STATES | $190.5K | 8 |
| DR. REDDYS LABORATORIES INC | UNITED STATES | $150.0K | 3 |
| DR.REDDYS LABORATORIES,INC | UNITED STATES | $118.3K | 3 |
| DR REDDYS LABORATORIES INC | UNITED STATES | $109.6K | 3 |
| DR.REDDYS LABORATORIES INC. | UNITED STATES | $105.3K | 3 |
Dr.reddy's Laboratories Ltd supplies Ofloxacin to 20 buyers globally. The largest buyer is DR, REDDYS LABORATORIES, INC (UNITED STATES), followed by NORTHSTAR DISTRIBUTION CENTRE 8912 (UNITED STATES) and DR.REDDY'S LABORATORIES,INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ofloxacin Export Value and How Much Does Dr.reddy's Laboratories Ltd Contribute?
India exported $71.8M worth of Ofloxacin through 15,000 shipments from 1094 suppliers to 180 countries, serving 3,093 buyers globally. Dr.reddy's Laboratories Ltd contributes $3.7M to this total, accounting for 1.3% of India's Ofloxacin exports. Dr.reddy's Laboratories Ltd ships Ofloxacin to 7 countries through 20 buyers.
What Is the Average Shipment Value for Dr.reddy's Laboratories Ltd's Ofloxacin Exports?
Dr.reddy's Laboratories Ltd's average Ofloxacin shipment value is $50.0K per consignment, based on 74 shipments totaling $3.7M. The largest destination is UNITED STATES (95.5% of Dr.reddy's Laboratories Ltd's Ofloxacin exports).
How Does Dr.reddy's Laboratories Ltd Compare to Other Indian Ofloxacin Exporters?
Dr.reddy's Laboratories Ltd ranks #1 among 1094 Indian Ofloxacin exporters with a 1.3% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($12.2M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($10.1M), MICRO LABS LIMITED ($8.4M). Dr.reddy's Laboratories Ltd processed 74 shipments to 2 destination countries.
What Ofloxacin Formulations Does Dr.reddy's Laboratories Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $1.1M | 23 |
| LEVOFLOXACIN TABLETS 750MG 30S(TOTAL QT | $261.5K | 6 |
| 300038454 Ciprofloxacin 0.3% and Dexamet | $250.0K | 5 |
| CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% OTIC SUSPENSION USP 7.5ML BOTTLE | $200.0K | 4 |
| 300038454 CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% OTIC SUSPENSION USP 7.5ML BOTTLE NS, BATCH-23020279 MFG-01.11.2023 ENOS | $150.0K | 3 |
| CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% OTIC SUSPENSION USP 7.5ML BOTTLE (23280 NOS)NOS | $150.0K | 3 |
| CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% OTIC SUSPENSION USP 7.5ML BOTTLE (23328 NOS)NOS | $150.0K | 3 |
| CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% OTIC SUSPENSION USP 7.5ML BOTTLE (23376 NOS)NOS | $150.0K | 3 |
| CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% OTIC SUSPENSION USP 7.5ML BOTTLE (45744 NOS)NOS | $150.0K | 3 |
| 300038454 CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% OTIC SUSPENSION USP 7.5ML BOTTLE NS BATCH-23020281 MFG-01.12.2023 ENOS | $150.0K | 3 |
Dr.reddy's Laboratories Ltd exports 66 distinct Ofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 with 23 shipments worth $1.1M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Ofloxacin to Key Markets
What Dr.reddy's Laboratories Ltd must comply with to export Ofloxacin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Dr.reddy's Laboratories Ltd Compare to Nearest Ofloxacin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | MANKIND PHARMA LIMITED | $6.1M | 160 | 3 | $38.4K |
| 10 | FDC LIMITED | $5.5M | 110 | 5 | $50.0K |
| 1 | DR.REDDY'S LABORATORIES LTD ★ | $3.7M | 74 | 2 | $50.0K |
| 15 | ZYDUS LIFESCIENCES LIMITED | $3.4M | 96 | 14 | $35.6K |
| 8 | MEDOPHARM | $3.1M | 62 | 15 | $50.0K |
Dr.reddy's Laboratories Ltd ranks #1 among 1094 Indian Ofloxacin exporters. Average shipment value of $50.0K compared to the market average of $65.6K. The closest competitors by value are MANKIND PHARMA LIMITED and FDC LIMITED.
Which Indian Ports Ship Ofloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,841 | 12.3% |
| DELHI AIR CARGO ACC (INDEL4) | 1,504 | 10.0% |
| SAHAR AIR | 1,292 | 8.6% |
| NHAVA SHEVA SEA (INNSA1) | 1,262 | 8.4% |
| DELHI AIR | 894 | 6.0% |
| Bombay Air | 655 | 4.4% |
| JNPT/ NHAVA SHEVA SEA | 645 | 4.3% |
| Delhi Air | 361 | 2.4% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Dr.reddy's Laboratories Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 128 individual customs records matching Dr.reddy's Laboratories Ltd exporting Ofloxacin, covering 66 formulations to 7 countries via 20 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 3,093+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ofloxacin Export Data from Dr.reddy's Laboratories Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dr.reddy's Laboratories Ltd's Ofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Dr.reddy's Laboratories Ltd
Company Profile
0 products · $0 total trade · 0 categories
Ofloxacin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Dr.reddy's Laboratories Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ofloxacin. For current shipment-level data, contact TransData Nexus.